11 Recruiting Trials

Clinical Trials
for Lupus in Oklahoma

11 clinical trials for Lupus are currently recruiting participants at study sites in Oklahoma. Study-related care is provided at no cost.

11
Recruiting trials
5
Study sites
1
City
7
Industry-sponsored
1
Phase 2
3
Phase 3

Lupus clinical trials in Oklahoma: what to expect

Lupus trials are mostly for systemic lupus that stays active despite standard treatment. They test biologic infusions and injections that target the immune signals behind lupus, new oral medicines, and treatments that reduce the need for steroids. Lupus nephritis, where the disease affects the kidneys, has its own trials with their own entry rules, and cell-based therapies are beginning to be tested in people whose lupus has not responded to anything else.

In Oklahoma, recruiting lupus studies are concentrated in Oklahoma City. 7 of the 11 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who lupus trials usually look for

Trials require a confirmed diagnosis with positive antibody tests, active disease above a threshold on a standard activity score at screening, and a stable regimen of your current medicines (an antimalarial, an immunosuppressant, a steroid below a stated dose) for several weeks beforehand. Lupus nephritis trials need a recent kidney biopsy and a protein-in-urine level above a cut-off. Common exclusions are severe active lupus of the brain, a recent biologic, serious infection and pregnancy. Ages are usually 18 to 75.

What taking part involves

Screening includes blood and urine tests and a review of your records. Most trials then last a year with visits every four weeks for an infusion or injection, lab monitoring and a disease-activity exam, often with a plan to taper steroids. The study drug is usually compared with placebo, both added to your existing treatment, and flares are treated as needed. An open-label extension generally follows. All study care is free and visits are usually paid.

Questions worth asking the study team

Whether your current medicines stay unchanged; how the steroid taper works; the chance of placebo and whether an extension follows; what happens during a flare; and what the trial means for pregnancy planning.

Showing 11 of 11 recruiting Lupus trials in Oklahoma

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
PHASE3 Avondale, Arizona +4 sites NCT06617325
This trial is looking for people aged 16 and older who have moderate to severe systemic lupus erythematosus (SLE) and are not getting enough improvement from their current medications. Participants will receive dapirolizumab pegol as an additional treatment along with their existing medications.
Recruiting
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
PHASE3 Anniston, Alabama +4 sites NCT07430306
This trial is looking for adults with systemic lupus erythematosus (SLE) who have not used immunosuppressive drugs before. Participants will receive anifrolumab as an additional treatment to their regular medications for SLE.
Recruiting
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
PHASE3 Los Angeles, California +4 sites NCT05799378
This trial is looking for older adults with lupus who want to see if they can safely stop taking hydroxychloroquine. Participants will be monitored for one year to check their disease activity.
Recruiting
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
PHASE2 Beverly Hills, California +4 sites NCT07409181
This trial is looking for adults with systemic lupus erythematosus (SLE) to see if a medicine called BI 3000202 can help them. Participants will take the medicine or a placebo for one year while continuing their regular SLE treatment.
Recruiting
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
PHASE4 Oklahoma City, Oklahoma +3 sites NCT06875960
This trial is looking for people who have lupus and want to continue their treatment with Deucravacitinib. To join, you need to have finished certain previous studies and be assessed by a doctor to see if you can benefit from further treatment.
Recruiting
Safety of the Herpes Zoster Subunit Vaccine in Lupus
PHASE4 Oklahoma City, Oklahoma +1 sites NCT05559671
This trial is looking for adults with Systemic Lupus Erythematosus who are interested in participating in a study about a herpes vaccine. Participants will receive either the herpes vaccine or a placebo and will be monitored for safety and immune response.
Recruiting
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
PHASE4 Glendale, Arizona +4 sites NCT07225387
This trial is looking for adults with lupus nephritis to see if a combination of two medications helps improve kidney function. Participants will receive treatments and undergo health assessments over time.
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
PHASE1 Oklahoma City, Oklahoma +4 sites NCT06576271
This trial is looking for healthy individuals and people with systemic lupus erythematosus (SLE) to evaluate a new treatment. Participants will undergo medical evaluations and may need to provide blood samples.
Recruiting
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
N/A La Jolla, California +4 sites NCT07175285
This trial is looking for people with active systemic lupus erythematosus who have not responded well to previous treatments. Participants will need to meet specific health criteria and may undergo assessments to evaluate their condition.
Recruiting
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
N/A Chicago, Illinois +4 sites NCT00198068
This trial is looking for pregnant women with systemic lupus erythematosus or antiphospholipid syndrome to understand how certain proteins may affect pregnancy outcomes. Participants will be monitored throughout their pregnancy to see if these proteins can predict complications.
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
PHASE1 Beverly Hills, California +4 sites NCT06308978
This trial is looking for people between the ages of 12 and 70 who have certain autoimmune diseases that are not responding to previous treatments. They should generally be in good health, but not have serious heart or lung problems, active infections, or recent cancer. Also, women can't be pregnant or breastfeeding, and participants need to weigh at least 50 kg.
Recruiting

Where the Lupus studies are in Oklahoma

  • Oklahoma Medical Research Foundation, Oklahoma City7 trials
  • GSK Investigational Site, Oklahoma City1 trial
  • Research Site, Oklahoma City1 trial
  • Sl0044 50262, Oklahoma City1 trial
  • University of Oklahoma, Oklahoma City1 trial

Counts are recruiting studies listing at least one site in Oklahoma, from ClinicalTrials.gov, refreshed every two days.

Lupus clinical trials in Oklahoma: common questions

How many Lupus clinical trials are recruiting in Oklahoma?
TrialFinder currently lists 11 recruiting Lupus clinical trials with study sites in Oklahoma. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Lupus clinical trials located in Oklahoma?
Study sites for the Lupus trials listed on this page include Oklahoma City. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Lupus clinical trial in Oklahoma?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Lupus trials in Oklahoma also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Lupus clinical trial in Oklahoma?
Each study sets its own criteria based on age, Lupus diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Will my regular lupus medicines stop if I join a trial?
No. Lupus trials add the study treatment to a stable regimen of your current medicines. Many include a planned steroid taper as one of the goals, managed by the study doctor.
Is there a placebo in lupus trials?
Usually, but always on top of standard treatment, never instead of it, and most trials move everyone onto the active drug in an extension after the main study period.
Can I join a trial if I have lupus nephritis?
Yes. Lupus nephritis has dedicated trials that require a recent kidney biopsy and a stated level of protein in the urine. General lupus trials often exclude active nephritis, so look for the ones that name it.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Lupus trials near you in Oklahoma.

Get Matched — Free
No insurance required

Lupus trials evaluate belimumab, anifrolumab, JAK inhibitors, and other biologics targeting the immune dysregulation behind systemic lupus erythematosus.

All Lupus trials →